Breaking barriers: the evolution of portable colposcopes in cervical health

Sumedha Gupta; Archana Mishra; Saritha Shamsunder

doi:10.18203/2320-1770.ijrcog20240160

Authors

Sumedha Gupta Department of Obstetrics and Gynaecology, VMMC and SJH, New Delhi, India
Archana Mishra Department of Obstetrics and Gynaecology, VMMC and SJH, New Delhi, India
Saritha Shamsunder Department of Obstetrics and Gynaecology, VMMC and SJH, New Delhi, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20240160

Keywords:

Cervical cancer, Low resource setting, Cervical imaging devices

Abstract

Global calls for cervical cancer elimination prompt urgent focus on low-income countries where screening challenges persist. While high-income nations utilize advanced methods like human papillomavirus (HPV) testing and colposcopy, many low-resource settings rely on cost-effective approaches like visual assessment with acetic acid (VIA) performed on the same day as screening and treatment. This review explores the feasibility of implementing improved visual assessment methods in low and middle-income countries (LMICs), considering challenges posed by systemic factors. Emphasizing the vital role of visual inspection, particularly in high-income countries where colposcopy guides biopsies and treatment decisions, the article advocates for tailored screening pathways. Unlike extensive multi-step processes in high-income countries, LMICs face limitations in clinic visits, making simple VIA crucial. The article evaluates the potential of cervical imaging devices for low-resource settings, aiming to enhance cervical cancer screening in line with global elimination goals.

Metrics

Metrics Loading ...

References

Take action to help end the suffering caused by cervical cancer. Geneva: World Health Organization. 2013. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer?gclid=CjwK CAiAqNSsBhAvEiwAn_tmxSoei9YlhxjYKL61JbIqPpWXKahpb_ep9iUl-VohUOf_OYc098Ti9Bo CqdsQAvD_BwE. Accessed on 12 October 2023.

Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015. JAMA Oncol. 2017;3:524.

World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013. Available at: https://www.who.int/news-room/fact-sheets/detail/ cervical-cancer?gclid=CjwKCAiAqNSsBhAvEiw An_tmxeEyo-vcxG7wOTKbTMuunTJuiCQxAdb WdHh6qlxryA3odbEWk8sVzBoCq_0QAvD_BwE. Accessed on 12 October 2023.

Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. E Cancer Med Sci. 2015;9:530.

International agency for research on Cancer. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners’ manual. Available at: https://screening.iarc.fr/doc/Colposcopymanual.pdf. Accessed on 12 October 2023.

Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45:2640-8.

Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer. 2004;91:935.

Bigoni J, Gundar M, Tebeu P-M, Bongoe A, Schäfer S, Fokom-Domgue J, et al. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer. 2015;137:127.

De Vuyst H, Claeys P, Njiru S, Muchiri L, Steyaert S, De Sutter P, et al. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynecol Obstet. 2005;89:120.

Sankaranarayanan R, Shastri SS, Basu P, Mahé C, Mandal R, Amin G, et al. The role of low-level magnification in visual inspection with acetic. acid for the early detection of cervical neoplasia. Cancer Detect Prev. 2004;28:345.

Novikova, T. Optical techniques for cervical neoplasia detection. Beilstein J Nanotechnol. 2017;8:1844-62.

Safaeian M, Solomon D, Castle PE. Cervical cancer prevention—Cervical screening: Science in evolution. Obstet. Gynecol. Clin N Am. 2007;34:739-60.

Sahebali S, Van den Eynden G, Murta EF, Michelin MA, Cusumano P, Petignat P, et al. Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development. Eur J Cancer Prev. 2010;19(3):204-15.

Pupa SM, Ménard S, Forti S, Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol. 2002;192:259-67.

Hong WK, Sporn MB. Recent Advances in Chemoprevention of Cancer. Science. 1997;278:1073.

Ingber DE. Cancer as a disease of epithelial–mesenchymal interactions and extracellular matrix regulation. Differentiation. 2002;70:547-60.

Arifler D, Pavlova I, Gillenwater A, Richards-Kortum R. Light Scattering from Collagen Fiber Networks: Micro-Optical Properties of Normal and Neoplastic Stroma. Biophys J. 2007;92:3260-74.

Stoler MH, Schiffman M; Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285(11):1500-5.

Sritipsukho P, Thaweekul Y. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: A systematic review. J Med Assoc Thai. 2010;93(7):S254-61.

Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153-60.

Catarino R, Schäfer S, Vassilakos P, Petignat P, Arbyn M. Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis. BJOG. 2018;125(5):545-53.

Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM. Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):221-32.

Raifu AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, Walter SD, Franco EL; Congo Screening Study Group. Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician. PLoS One. 2017;12(1):e0170631.

Xie Y, Tan X, Shao H, Liu Q, Tou J, Zhang Y, Luo Q, Xiang Q. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation. BMC Public Health. 2017;17(1):118.

Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300-4.

Rosenblum HG, Lewis RM, Gargano JW, Querec TD, Unger ER, Markowitz LE. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018. MMWR Morb Mortal Wkly Rep. 2021;70(12):415-20.

World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017- recommendations. Vaccine. 2017;35:5753-5.

Asiedu MN, Agudogo JS, Dotson ME, Skerrett E, Krieger MS, Lam CT, et al. A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system. Sci Rep. 2020;10(1):16570.

Asiedu MN, Agudogo J, Krieger MS, Miros R, Proeschold-Bell RJ, Schmitt JW, et al. Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening. PLoS One. 2017;12(5):e0177782.

Asiedu MN, Simhal A, Lam CT, Mueller J, Chaudhary U, Schmitt JW, et al. Image processing and machine learning techniques to automate diagnosis of Lugol’s iodine cervigrams for a low-cost point-of-care digital colposcope. Proceedings of the SPIE. 2018;10485:10.

Asiedu MN, Simhal A, Chaudhary U, Mueller JL, Lam CT, Schmitt JW, et al. Development of Algorithms for Automated Detection of Cervical Pre-Cancers With a Low-Cost, Point-of-Care, Pocket Colposcope. IEEE Trans Biomed Eng. 2019;66(8):2306-18.

Quinn MK, Bubi TC, Pierce MC, Kayembe MK, Ramogola-Masire D, Richards-Kortum R. High-resolution microendoscopy for the detection of cervical neoplasia in low-resource settings. PLoS One. 2012;7(9):e44924.

Pierce M, Yu D, Richards-Kortum R. High-resolution fiber-optic microendoscopy for in situ cellular imaging. J Vis Exp. 2011;(47):2306.

Quang T, Schwarz RA, Dawsey SM, Tan MC, Patel K, Yu X, et al. A tablet-interfaced high-resolution microendoscope with automated image interpretation for real-time evaluation of esophageal squamous cell neoplasia. Gastrointest Endosc. 2016;84(5):834-41.

Parra S, Carranza E, Coole J, Hunt B, Smith C, Keahey P, et al. Development of Low-Cost Point-of-Care Technologies for Cervical Cancer Prevention Based on a Single-Board Computer. IEEE J Transl Eng Health Med. 2020;8:4300210.

Hunt B, Fregnani JHTG, Schwarz RA, Pantano N, Tesoni S, Possati-Resende JC, et al. Diagnosing Cervical Neoplasia in Rural Brazil Using a Mobile Van Equipped with In Vivo Microscopy: A Cluster-Randomized Community Trial. Cancer Prev Res (Phila). 2018;11(6):359-70.

Parra SG, Rodriguez AM, Cherry KD, Schwarz RA, Gowen RM, Guerra LB, et al. Low-cost, high-resolution imaging for detecting cervical precancer in medically-underserved areas of Texas. Gynecol Oncol. 2019;154(3):558-64.

Grant BD, Fregnani JH, Possati Resende JC, Scapulatempo-Neto C, Matsushita GM, Mauad EC, et al. High-resolution microendoscopy: a point-of-care diagnostic for cervical dysplasia in low-resource settings. Eur J Cancer Prev. 2017;26(1):63-70.

Hunt B, Fregnani JHTG, Brenes D, Schwarz RA, Salcedo MP, Possati-Resende JC, et al. Cervical lesion assessment using real-time microendoscopy image analysis in Brazil: The CLARA study. Int J Cancer. 2021;149(2):431-41.

Vila PM, Park CW, Pierce MC, Goldstein GH, Levy L, Gurudutt VV, et al. Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer. Ann Surg Oncol. 2012;19(11):3534-9.

Muldoon TJ, Roblyer D, Williams MD, Stepanek VM, Richards-Kortum R, Gillenwater AM. Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope. Head Neck. 2012;34(3):305-12.

Vila PM, Thekkek N, Richards-Kortum R, Anandasabapathy S. Use of in vivo real-time optical imaging for esophageal neoplasia. Mt Sinai J Med. 2011;78(6):894-904.

Pierce MC, Schwarz RA, Bhattar VS, Mondrik S, Williams MD, Lee JJ, et al. Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia. Cancer Prev Res (Phila). 2012;5(6):801-9.

Gonzalez M, Montejo KA, Krupp K, Srinivas V, DeHoog E, Madhivanan P, et al. Design and implementation of a portable colposcope Mueller matrix polarimeter. J Biomed Opt. 2020;25(11):116006.

Ramella-Roman JC, Gonzalez M, Chue-Sang J, Montejo K, Krup K, Srinivas V, et al. Development and characterization of a snapshot Mueller matrix polarimeter for the determination of cervical cancer risk in the low resource setting. Proceedings of the SPIE. 2018;10485:12.

Peterson CW, Rose D, Mink J, Levitz D. Real-Time Monitoring and Evaluation of a Visual-Based Cervical Cancer Screening Program Using a Decision Support Job Aid. Diagnostics (Basel). 2016;6(2):20.

Mayoore J, Matt H, Liming H, Yau BO, Cary C, Benjamin W, et al. Characterization of cervigram image sharpness using multiple self-referenced measurements and random forest classifiers. Proc SPIE. 2018;1048507.

Marta M, Sonia C, Octavio V, Bruce SK, Amit S, David L. Mobile colposcopy in urban and underserved suburban areas in Baja California. Proc SPIE. 2018;9699:5.

Ngonzi J, Bajunirwe F, Wistrand C, Mayanja R, Altman D, Thorsell M, et al. Agreement of colposcope and gynocular in assessment of cervical lesions by swede score: a randomized, crossover pilot trial. J Low Genit Tract Dis. 2013;17(4):372-7.

Nessa A, Roy JS, Chowdhury MA, Khanam Q, Afroz R, Wistrand C, et al. Evaluation of the accuracy in detecting cervical lesions by nurses versus doctors using a stationary colposcope and Gynocular in a low-resource setting. BMJ Open. 2014;4(11):e005313.

Nessa A, Wistrand C, Begum SA, Thuresson M, Shemer I, Thorsell M, et al. Evaluation of stationary colposcope and the Gynocular, by the Swede score systematic colposcopic system in VIA positive women: a crossover randomized trial. Int J Gynecol Cancer. 2014;24(2):339-45.

Kallner HK, Persson M, Thuresson M, Altman D, Shemer I, Thorsell M, et al. Diagnostic colposcopic accuracy by the gynocular and a stationary colposcope. Int J Technol Assess Health Care. 2015;31(3):181-7.

Basu P, Banerjee D, Mittal S, Mandal R, Ghosh I, Das P, et al. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India. Cancer Causes Control. 2016;27(10):1253-9.

Srinivas V, Nishimura HM, Jayakrishna P, Krupp K, Madhivanan P, Madhunapantula SV. Evaluating the feasibility of utilizing Gynocular-triage-to-diagnose application with VIA (Visual inspection with Acetic acid) in community cervical cancer screening programs in rural Mysore, India. Indian J Cancer. 2021;58(3):409-16.

Singh N, Negi N, Sharma S, Singh T. Diagnostic Role of Portable Colposcope (Gynocular) for Diagnosis of Pre-Invasive Lesions of Cervix. Indian J Gynecol Oncol. 2020;18:69.